Paper26110901
The Value of Intraoperative Near-Infrared Fluorescence Imaging Based on Enhanced Permeability and Retention of Indocyanine Green: Feasibility and False-Positives in Ovarian Cancer.
Tummers QR and 8 others. PLoS One, 2015. Cited by 122 papers, by iCite.
Cite this record
ConductScience Library. The Value of Intraoperative Near-Infrared Fluorescence Imaging Based on Enhanced Permeability and Retention of Indocyanine Green: Feasibility and False-Positives in Ovarian Cancer. Papers, record 26110901. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26110901
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Value of Intraoperative Near-Infrared Fluorescence Imaging Based on Enhanced Permeability and Retention of Indocyanine Green: Feasibility and False-Positives in Ovarian Cancer.
- PubMed
- Publication types
- Clinical Trial, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasm Metastasis | Major topic |
| Ovarian Neoplasms | Major topic |
| Adult | |
| Aged | |
| Female | |
| Fluorescent Dyes | |
| Humans | |
| Indocyanine Green | |
| Middle Aged | |
| Monitoring, Intraoperative | |
| Optical Imaging | |
| Permeability |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 CA115296 | NCI NIH HHS | United States | R01CA115296 | PubMed and NIH |
| R01-CA-115296 | NCI NIH HHS | United States | R01CA115296 | PubMed and NIH |
Source NIH RePORTER
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1234624 | Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. | Natl Cancer Inst Monogr | 1975 | https://conductscience.org/library/papers/1234624 | PubMed |
| 2 | 21177396 | Breast cancer: early- and late-fluorescence near-infrared imaging with indocyanine green--a preliminary study. | Radiology | 2011 | https://conductscience.org/library/papers/21177396 | PubMed |
| 3 | 8166218 | The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. | Am J Obstet Gynecol | 1994 | https://conductscience.org/library/papers/8166218 | PubMed |
| 4 | 9887245 | Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients. | Gynecol Oncol | 1998 | https://conductscience.org/library/papers/9887245 | PubMed |
| 5 | 17018256 | Ovarian cancer. | Crit Rev Oncol Hematol | 2006 | https://conductscience.org/library/papers/17018256 | PubMed |
| 6 | 21351269 | Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. | Int J Cancer | 2010 | https://conductscience.org/library/papers/21351269 | PubMed |
| 7 | 21296855 | Global cancer statistics. | CA Cancer J Clin | 2011 | https://conductscience.org/library/papers/21296855 | PubMed |
| 8 | 20441782 | The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. | Adv Drug Deliv Rev | 2011 | https://conductscience.org/library/papers/20441782 | PubMed |
| 9 | 21469142 | Near infrared fluorescence-guided real-time endoscopic detection of peritoneal ovarian cancer nodules using intravenously injected indocyanine green. | Int J Cancer | 2011 | https://conductscience.org/library/papers/21469142 | PubMed |
| 10 | 21495033 | The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. | J Surg Oncol | 2011 | https://conductscience.org/library/papers/21495033 | PubMed |
| 11 | 21360250 | Toward optimization of imaging system and lymphatic tracer for near-infrared fluorescent sentinel lymph node mapping in breast cancer. | Ann Surg Oncol | 2011 | https://conductscience.org/library/papers/21360250 | PubMed |
| 12 | 21926976 | Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results. | Nat Med | 2011 | https://conductscience.org/library/papers/21926976 | PubMed |
| 13 | 22450535 | Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting. | Proc Jpn Acad Ser B Phys Biol Sci | 2012 | https://conductscience.org/library/papers/22450535 | PubMed |
| 14 | 23495730 | The link between infection and cancer: tumor vasculature, free radicals, and drug delivery to tumors via the EPR effect. | Cancer Sci | 2013 | https://conductscience.org/library/papers/23495730 | PubMed |
| 15 | 23881033 | Image-guided cancer surgery using near-infrared fluorescence. | Nat Rev Clin Oncol | 2013 | https://conductscience.org/library/papers/23881033 | PubMed |
| 16 | 23794086 | Near-infrared fluorescence-guided resection of colorectal liver metastases. | Cancer | 2013 | https://conductscience.org/library/papers/23794086 | PubMed |
| 17 | 23720199 | Intraoperative near-infrared fluorescence imaging of parathyroid adenomas with use of low-dose methylene blue. | Head Neck | 2014 | https://conductscience.org/library/papers/23720199 | PubMed |
| 18 | 24862545 | Real-time intraoperative detection of breast cancer using near-infrared fluorescence imaging and Methylene Blue. | Eur J Surg Oncol | 2014 | https://conductscience.org/library/papers/24862545 | PubMed |
| 19 | 10699287 | Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. | J Control Release | 2000 | https://conductscience.org/library/papers/10699287 | PubMed |
| 20 | 10706610 | Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. | Proc Natl Acad Sci U S A | 2000 | https://conductscience.org/library/papers/10706610 | PubMed |
Cited by78
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 122 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42569871 | Near-Infrared Fluorescence Imaging and Photothermal Therapy of Tumors Using a Targeted Helical Protein Scaffold. | ACS Appl Bio Mater | 2026 | https://conductscience.org/library/papers/42569871 | PubMed |
| 42198268 | Emerging Near-Infrared Targeted Imaging Pharmaceutics for Ovarian Cancer. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42198268 | PubMed |
| 42149185 | Optical and Optoacoustic Imaging Probes. | Recent Results Cancer Res | 2026 | https://conductscience.org/library/papers/42149185 | PubMed |
| 42110997 | Defining the optimal imaging time point for fluorescence-lifetime-based tumor identification using the non-targeting near-infrared dye indocyanine green and post-processed high-dynamic-range images. | Biomed Opt Express | 2026 | https://conductscience.org/library/papers/42110997 | PubMed |
| 42048455 | An Octopus probe for high-performance >1,300 nm NIR-II fluorescence molecular imaging of cancer. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/42048455 | PubMed |
| 41927279 | Translation of Intraoperative Molecular Imaging for Clinical Use. | J Nucl Med | 2026 | https://conductscience.org/library/papers/41927279 | PubMed |
| 41875349 | Erasable FAP Targeted Spray-On Probe for Fluorescence-Guided Surgery. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41875349 | PubMed |
| 41514657 | Fluorescence-Guided Surgery in Pediatric Oncology: Current Practice and Future Directions. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41514657 | PubMed |
| 40928629 | Investigating the mechanisms of indocyanine green tumour uptake in sarcoma cell lines and ex vivo human tissue. | J Pathol | 2025 | https://conductscience.org/library/papers/40928629 | PubMed |
| 40859273 | Application of fluorescent tracers in ovarian cancer surgical navigation: a systematic review and meta-analysis. | World J Surg Oncol | 2025 | https://conductscience.org/library/papers/40859273 | PubMed |
| 40839323 | Dual-functional Anti-hPSMAEC domain nanocapsules for targeted inhibition of prostate tumor growth. | Apoptosis | 2025 | https://conductscience.org/library/papers/40839323 | PubMed |
| 39770053 | Review of Clinically Assessed Molecular Fluorophores for Intraoperative Image Guided Surgery. | Molecules | 2024 | https://conductscience.org/library/papers/39770053 | PubMed |
| 39629534 | The Use of Fluorescent Markers to Detect and Delineate Head and Neck Cancer: A Scoping Review. | Clin Otolaryngol | 2025 | https://conductscience.org/library/papers/39629534 | PubMed |
| 39543737 | Near-infrared fluorescent molecular probes with cetuximab in the in vivo fluorescence imaging for epithelial ovarian cancer. | J Ovarian Res | 2024 | https://conductscience.org/library/papers/39543737 | PubMed |
| 39123417 | MIRRORS ICG: Perfusion Assessment Using Indocyanine Green (ICG) Peritoneal Angiography during Robotic Interval Cytoreductive Surgery for Advanced Ovarian Cancer. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39123417 | PubMed |
| 38368490 | Fluorescence-guided minimally-invasive resection of abdominal paragangliomas using indocyanine green. | Sci Rep | 2024 | https://conductscience.org/library/papers/38368490 | PubMed |
| 37448778 | Quickly evolving near-infrared photoimmunotherapy provides multifaceted approach to modern cancer treatment. | View (Beijing) | 2022 | https://conductscience.org/library/papers/37448778 | PubMed |
| 37374073 | The Value of Indocyanine Green Image-Guided Surgery in Patients with Primary Liver Tumors and Liver Metastases. | Life (Basel) | 2023 | https://conductscience.org/library/papers/37374073 | PubMed |
| 37272787 | Glutathione-Exhausting Nanoprobes for NIR-II Fluorescence Imaging-Guided Surgery and Boosting Radiation Therapy Efficacy via Ferroptosis in Breast Cancer. | ACS Nano | 2023 | https://conductscience.org/library/papers/37272787 | PubMed |
| 37252358 | Protease Activated Probes for Real-Time Ratiometric Imaging of Solid Tumors. | ACS Cent Sci | 2023 | https://conductscience.org/library/papers/37252358 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FOLR1 | 2348 | PubTator's text mining | https://conductscience.org/library/genes/2348 | NCBI Gene |
| KNG1 | 3827 | PubTator's text mining | https://conductscience.org/library/genes/3827 | NCBI Gene |
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| ISRCTN | ISRCTN16945066 |
Source ISRCTN
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26110901
GET https://conductscience.org/api/papers/v1/26110901/references?page=2